Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy

Figure 5

Effect of bevacizumab (Bev) on phosphorylation of FAK and Pyk2 in rat intracranial glioma model. (A) Protein expression and phosphorylated FAK at Tyr397 and Pyk2 at Tyr402 in intracranial glioma tissue of rats treated with Bev or IgG control. (B, C) Quantification of total protein levels and phosphorylation of Pyk2 in (A). (D, E) Quantification of total protein levels and its phosphorylation of FAK in (A). (**p < 0.01, vs. IgG control).

Back to article page